SAN MATEO, Calif.--(BUSINESS WIRE)--Deltagen, Inc. (Pink Sheets:DGEN), a leading provider of drug discovery tools to the biopharmaceutical industry, today reported unaudited consolidated financial results for the three months ended September 30, 2011 and announces that the Company’s wholly-owned subsidiary, Deltagen BioServices, Inc. (“Deltagen BioServices”), has received $1.275 million as part of fund-raising efforts to fund the operations of Deltagen BioServices.
